Beaulieu, M.-E.; MartÃnez-MartÃn, S.; Kaur, J.; Castillo Cano, V.; Massó-Vallés, D.; Foradada Felip, L.; López-Estévez, S.; Serrano del Pozo, E.; Thabussot, H.; Soucek, L.
Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue. Cancers 2023, 15, 826.
https://doi.org/10.3390/cancers15030826
AMA Style
Beaulieu M-E, MartÃnez-MartÃn S, Kaur J, Castillo Cano V, Massó-Vallés D, Foradada Felip L, López-Estévez S, Serrano del Pozo E, Thabussot H, Soucek L.
Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue. Cancers. 2023; 15(3):826.
https://doi.org/10.3390/cancers15030826
Chicago/Turabian Style
Beaulieu, Marie-Eve, Sandra MartÃnez-MartÃn, Jastrinjan Kaur, Virginia Castillo Cano, Daniel Massó-Vallés, Laia Foradada Felip, Sergio López-Estévez, Erika Serrano del Pozo, Hugo Thabussot, and Laura Soucek.
2023. "Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue" Cancers 15, no. 3: 826.
https://doi.org/10.3390/cancers15030826
APA Style
Beaulieu, M.-E., MartÃnez-MartÃn, S., Kaur, J., Castillo Cano, V., Massó-Vallés, D., Foradada Felip, L., López-Estévez, S., Serrano del Pozo, E., Thabussot, H., & Soucek, L.
(2023). Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue. Cancers, 15(3), 826.
https://doi.org/10.3390/cancers15030826